STERTZER SIMON H
SEC Form 4 insider trading activity
STERTZER SIMON H has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, STERTZER SIMON H is listed as Director at BioCardia, Inc. Inside the rolling window, STERTZER SIMON H reported 2 open-market purchases totaling $104K in BCDA and no open-market sales. The largest disclosed transaction in the window is a purchase of 70,200 BCDA shares on Jun 22, 2026, worth $65K.
Companies traded
Other insiders at BCDA
Insider Buying
$104K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 19, 2025 | BCDA | Purchase | $498K |
Frequently asked questions
How many SEC Form 4 filings has STERTZER SIMON H made?
STERTZER SIMON H has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does STERTZER SIMON H trade?
STERTZER SIMON H has filed SEC Form 4 disclosures for 1 company, including BCDA.
When was STERTZER SIMON H's most recent SEC Form 4 filing?
STERTZER SIMON H's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is STERTZER SIMON H's total buy and sell value in the current window?
Inside the rolling retention window, STERTZER SIMON H bought $104K and sold $0 based on SEC Form 4 filings.
What was STERTZER SIMON H's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 70,200 BCDA shares on 2026-06-22, worth $65K, per SEC Form 4 filings.